Median age | Â | 65.7 years (range, 36-86 years) | ||
---|---|---|---|---|
Sex (Male/Female) | Â | 62 (62.6%)/37 (37.4%) | ||
Histological diagnosis | Â | Â | Â | |
   Adenocarcinoma |  | 97 (98.0%) | ||
   Adenosquamous carcinoma | 2 (2.0%) |  | ||
pT category | Â | Â | Â | |
   pT1 |  |  | 6 (6.1%) |  |
   pT2 |  |  | 3 (3.0%) |  |
   pT3 |  |  | 57 (57.6%) | |
   pT4 |  |  | 33 (33.3%) | |
pN category | Â | Â | Â | |
   pN0 |  |  | 33 (33.3%) | |
   pN1 |  |  | 66 (66.7%) | |
UICC stage | Â | Â | Â | |
   IA & IB |  |  | 5 (5.1%) & 4 (4.0%) | |
   IIA & IIB |  |  | 21 (21.2%) & 64 (64.7%) | |
   III |  |  | 1 (1.0%) | |
   IV |  |  | 4 (4.0%) | |
Histological grade | Â | Â | Â | |
   G1 |  |  | 20 (20.2%) | |
   G2 |  |  | 43 (43.4%) | |
   G3 |  |  | 36 (36.4%) | |
Residual tumor category | Â | Â | ||
   R0 |  |  | 60 (61.2%) | |
   R1 |  |  | 38 (38.7%) | |
Vessel invasion | Â | Â | Â | |
   Positive |  |  | 61 (62.2%) | |
   Negative |  |  | 37 (37.7%) | |
Neural invasion | Â | Â | Â | |
   Positive |  |  | 84 (84.8%) | |
   Negative |  |  | 15 (15.2%) |